Propanc Biopharma, Inc. | Business Contracts

Securities Purchase Agreement, dated September 22, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc (Filed With SEC on September 28, 2021)

Amended and Restated Director Agreement, by and between the Company and Josef Zelinger, dated August 12, 2021 (Filed With SEC on August 18, 2021)

Indemnification Agreement, dated December 23, 2020, by and between Propanc Biopharma, Inc. and Josef Zelinger (Filed With SEC on December 30, 2020)

Employment Agreement, dated as of June 24, 2019, between Propanc PTY LTD and Carlo Campiciano (Filed With SEC on July 1, 2019)

8% Convertible Promissory Note, dated September 22, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc (Filed With SEC on September 28, 2021)

Securities Purchase Agreement, dated August 19, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc (Filed With SEC on August 25, 2021)

8% Convertible Promissory Note, dated August 19, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc (Filed With SEC on August 25, 2021)

Cancellation Agreement, by and between the Company and Dr. Julian Kenyon, dated August 12, 2021 (Filed With SEC on August 18, 2021)

Cancellation Agreement, by and between the Company and James Nathanielsz, dated August 12, 2021 (Filed With SEC on August 18, 2021)

Securities Purchase Agreement, dated March 16, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc (Filed With SEC on March 19, 2021)

8% Convertible Promissory Note, dated March 16, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc (Filed With SEC on March 19, 2021)

Securities Purchase Agreement, dated January 5, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc (Filed With SEC on January 11, 2021)

8% Convertible Promissory Note, dated January 5, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc (Filed With SEC on January 11, 2021)

Director Agreement, dated December 23, 2020, by and between Propanc Biopharma, Inc. and Josef Zelinger (Filed With SEC on December 30, 2020)

8% Convertible Redeemable Promissory Note, dated December 10, 2020, issued by the Company to GW Holdings Group, LLC (Filed With SEC on December 16, 2020)

Securities Purchase Agreement, dated December 10, 2020, by and between the Company and GW Holdings Group, LLC (Filed With SEC on December 16, 2020)

Securities Purchase Agreement, dated December 2, 2020, by and between the Company and Geneva Roth Remark Holdings, Inc (Filed With SEC on December 7, 2020)

8% Convertible Promissory Note, dated December 2, 2020, issued by the Company to Geneva Roth Remark Holdings, Inc (Filed With SEC on December 7, 2020)

Form of Registration Rights Agreement (Filed With SEC on April 3, 2020)

Form of Securities Purchase Agreement (Filed With SEC on April 3, 2020)

Form of Series C Warrant (Filed With SEC on April 3, 2020)

Form of Series B Warrant (Filed With SEC on April 3, 2020)

Form of Series A Warrant (Filed With SEC on April 3, 2020)

Form of Prefunded Warrant (Filed With SEC on April 3, 2020)

Form of Second Convertible Redeemable Promissory Note (Filed With SEC on January 17, 2020)

Form of Second Securities Purchase Agreement (Filed With SEC on January 17, 2020)

Form of First Securities Purchase Agreement (Filed With SEC on January 17, 2020)

Form of First Convertible Redeemable Promissory Note (Filed With SEC on January 17, 2020)

Form of Convertible Promissory Note (Filed With SEC on October 15, 2019)

Form of Securities Purchase Agreement (Filed With SEC on October 15, 2019)

Form of Securities Purchase Agreement (Filed With SEC on October 8, 2019)

Form of Convertible Redeemable Promissory Note (Filed With SEC on October 8, 2019)

Registration Rights Agreement dated August 30, 2019, by and between Propanc Biopharma, Inc. and Auctus Fund LLC (Filed With SEC on September 9, 2019)

Securities Purchase Agreement dated August 30, 2019, by and between Propanc Biopharma, Inc. and Auctus Fund LLC (Filed With SEC on September 9, 2019)

Common Stock Purchase Warrant for the purchase of up to 225,000 shares of Propanc Biopharma, Inc.s common stock (Filed With SEC on September 9, 2019)

Common Stock Purchase Warrant for the purchase of up to 300,000 shares of Propanc Biopharma, Inc.s common stock (Filed With SEC on September 9, 2019)

Common Stock Purchase Warrant for the purchase of up to 450,000 shares of Propanc Biopharma, Inc.s common stock (Filed With SEC on September 9, 2019)

Convertible Promissory Note, issued to Auctus Fund LLC on August 30, 2019 and effective as of September 3, 2019 (Filed With SEC on September 9, 2019)

Securities Purchase Agreement dated July 30, 2019, by and between Propanc Biopharma, Inc. and Odyssey Capital Funding LLC (Filed With SEC on August 6, 2019)

10% Convertible Note made in favor of Odyssey Capital Funding LLC (Filed With SEC on August 6, 2019)

8% Convertible Promissory Note, dated July 3, 2019, issued by the Company to Power Up Lending Group Ltd (Filed With SEC on July 10, 2019)

Securities Purchase Agreement, dated July 3, 2019, by and between the Company and Power Up Lending Group Ltd (Filed With SEC on July 10, 2019)

Form of Placement Agency Agreement (Filed With SEC on June 14, 2019)

Form of Securities Purchase Agreement (Filed With SEC on June 14, 2019)

Form of Placement Agent Warrant (Filed With SEC on June 14, 2019)

Form of Pre-Funded Warrant (Filed With SEC on June 14, 2019)

Form of Warrant (Filed With SEC on June 14, 2019)

Securities Purchase Agreement, dated May 23, 2019, by and between the Company and Redstart Holdings Corp (Filed With SEC on May 30, 2019)

8% Convertible Promissory Note, dated May 23, 2019, issued by the Company to Redstart Holdings Corp (Filed With SEC on May 30, 2019)

Amended and Restated Employment Agreement, dated as of May 14, 2019, between the Company and James Nathanielsz (Filed With SEC on May 15, 2019)

Form of Indemnification Agreement (Filed With SEC on May 15, 2019)

2019 Equity Incentive Plan (Filed With SEC on May 15, 2019)

Amended and Restated Services Agreement, dated as of May 14, 2019, between the Company and Dr. Julian Kenyon (Filed With SEC on May 15, 2019)

Registration Rights Agreement, dated February 25, 2019, by and between the Company and the Investor (Filed With SEC on February 25, 2019)

Equity Purchase Agreement, dated February 25, 2019, by and between the Company and the Investor (Filed With SEC on February 25, 2019)

Propanc Biopharma, Inc. (55)